Opaleye Management Inc. Q4 2017 Filing

Filed February 9, 2018

Portfolio Value

$312.3M

Holdings

35

Report Date

Q4 2017

Filing Type

13F-HR

All Holdings (35 positions)

#StockSharesValue% PortfolioType
1
AXGNAXOGEN INC
1,970,000$55.8M17.85%
2
2L9BLUEPRINT MEDICINES
735,000$55.4M17.75%
3
FGENEURFIBROGEN INC
360,000$17.1M5.46%
4
LOXO ONCOLOGY
176,300$14.8M4.75%
5
IMMUNOMEDICS INC
898,800$14.5M4.65%
6
CDXSCODEXIS INC
1,700,600$14.2M4.55%
7
XOMAXOMA CORP DEL
320,200$11.4M3.65%
8
ABLYNX NV
420,000$10.5M3.36%
9
CORIUM INTERNATIONAL INC
1,060,000$10.2M3.26%
10
GBYSANGAMO BIOSCIENCES INC
580,000$9.5M3.05%
11
STRONGBRIDGE BIOPHARMA PLC
1,250,000$9.1M2.90%
12
FRXFENNEC PHARMACEUTICALS INC
846,900$8.5M2.72%
13
AGIOAGIOS PHARMACEUTICALS
130,000$7.4M2.38%
14
AUDENTES THERAPEUTICS INC
210,000$6.7M2.13%
15
CRSPCRISPR THERAPEUTICS AG
281,000$6.6M2.11%
16
CBAYUSDCYMABAY THERAPEUTICS INC
665,000$6.1M1.96%
17
ARDXARDELYX
900,000$5.9M1.90%
18
FOAMIX PHARMACEUTICALS LTD
960,000$5.8M1.85%
19
ARGXARGENX
88,500$5.6M1.79%
20
NKTREURNEKTAR THERAPEUTICS
80,000$4.8M1.53%
21
INOTEK PHARMACEUTICALS CORP
1,802,000$4.7M1.51%
22
XLRNACCELERON PHARMA INC
101,500$4.3M1.38%
23
RAREULTRAGENYX PHARMACEUTICALS INC
90,000$4.2M1.34%
24
AMRNAMARIN CORP PLC
860,000$3.4M1.10%
25
DERMIRA INC
100,000$2.8M0.89%
26
CMRXEURCHIMERIX INC
600,000$2.8M0.89%
27
VKTXVIKING THERAPEUTICS INC
480,558$2.0M0.62%
28
QUREUNIQURE NV
90,801$1.8M0.57%
29
QTRXQUANTERIX CORP
65,000$1.4M0.45%
30
ACHILLION PHARMACEUTICALS INC
440,000$1.3M0.41%
31
PROTALIX BIOTHERAPEUTICS INC
1,825,000$1.2M0.39%
32
RYTMRHYTHM PHARMACEUTICALS INC
38,300$1.1M0.36%
33
SYROS PHARMACEUTICALS INC
74,074$720K0.23%
34
SPPIUSDSPECTRUM PHARMACEUTICALS INC
31,000$587K0.19%
35
BIOLINERX LTD
250,000$272K0.09%